Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 856 AL 870

The Effect of Aerobic Exercise on Cognitive Function in People with Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Zhang S, Zhen K, Su Q, Chen Y, Lv Y, Yu L.

Int J Environ Res Public Health. 2022 Nov 25;19(23):15700. doi: 10.3390/ijerph192315700.

[Physical activity in the elderly with a major neurocognitive disorder]

Mourey F, Ruffino C, Manckoundia P.

Soins Gerontol. 2022 Nov-Dec;27(158):35-38. doi: 10.1016/j.sger.2022.10.010. Epub 2022 Oct 25.

Identification of the Third Case of PSEN1 Tyr389His Variant in Early-Onset Alzheimer's Disease in Korea

Shim KH, Kang S, An SSA, Kang MJ.

Int J Mol Sci. 2022 Dec 19;23(24):16192. doi: 10.3390/ijms232416192.

How Telemedicine Can Improve the Quality of Care for Patients with Alzheimer's Disease and Related Dementias? A Narrative Review

Angelopoulou E, Papachristou N, Bougea A, Stanitsa E, Kontaxopoulou D, Fragkiadaki S, Pavlou D, Koros C, Değirmenci Y, Papatriantafyllou J, Thireos E, Politis A, Tsouros A, Bamidis P, Stefanis L, Papageorgiou S.

Medicina (Kaunas). 2022 Nov 22;58(12):1705. doi: 10.3390/medicina58121705.

Pharmacotherapy Evolution in Alzheimer's Disease: Current Framework and Relevant Directions

Miculas DC, Negru PA, Bungau SG, Behl T, Hassan SSU, Tit DM.

Cells. 2022 Dec 28;12(1):131. doi: 10.3390/cells12010131.

Aβ-Targeting Bifunctional Chelators (BFCs) for Potential Therapeutic and PET Imaging Applications

Krasnovskaya O, Kononova A, Erofeev A, Gorelkin P, Majouga A, Beloglazkina E.

Int J Mol Sci. 2022 Dec 23;24(1):236. doi: 10.3390/ijms24010236.

Informal Caregiving and Alzheimer's Disease: The Psychological Effect

Hellis E, Mukaetova-Ladinska EB.

Medicina (Kaunas). 2022 Dec 27;59(1):48. doi: 10.3390/medicina59010048.

The Impact of Physical Exercise on the Hippocampus in Physiological Condition and Ageing-Related Decline: Current Evidence from Animal and Human Studies

Lauretta G, Ravalli S, Maugeri G, D'Agata V, Rosa MD, Musumeci G.

Curr Pharm Biotechnol. 2022;23(2):180-189. doi: 10.2174/1389201022666210405142611.

An Agitated Patient With COVID-19 Infection and Early-onset Alzheimer Disease

Sykora D, Stonnington CM, Jain N.

Alzheimer Dis Assoc Disord. 2022 Jan-Mar 01;36(1):83-84. doi: 10.1097/WAD.0000000000000456.

Mild to moderate decrease in eGFR and cognitive decline in older adults

Grasing M, Kennedy K, Sarnak MJ, Burns JM, Gupta A.

Nephrol Dial Transplant. 2022 Jul 26;37(8):1499-1506. doi: 10.1093/ndt/gfab226.

Fish intake, n-3 fatty acid body status, and risk of cognitive decline: a systematic review and a dose-response meta-analysis of observational and experimental studies

Kosti RI, Kasdagli MI, Kyrozis A, Orsini N, Lagiou P, Taiganidou F, Naska A.

Nutr Rev. 2022 May 9;80(6):1445-1458. doi: 10.1093/nutrit/nuab078.

Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual

Schwarz CG, Knopman DS, Ramanan VK, Lowe VJ, Wiste HJ, Cogswell PM, Utianski RL, Senjem ML, Gunter JR, Vemuri P, Petersen RC, Jack CR.

J Alzheimers Dis. 2022;85(1):59-64. doi: 10.3233/JAD-215052.

A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease

Altomari N, Bruno F, Laganà V, Smirne N, Colao R, Curcio S, Di Lorenzo R, Frangipane F, Maletta R, Puccio G, Bruni AC.

J Alzheimers Dis. 2022;85(2):691-699. doi: 10.3233/JAD-215061.

Differential Cognitive Decline in Alzheimer's Disease Is Predicted by Changes in Ventricular Size but Moderated by Apolipoprotein E and Pulse Pressure

Sapkota S, McFall GP, Masellis M, Dixon RA, Black SE.

J Alzheimers Dis. 2022;85(2):545-560. doi: 10.3233/JAD-215068.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias